A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Apr 2, 2025

Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.

Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS

Feb 3, 2025

Authors: Quaresima P, Myers SH, Pintaudi B, D’Anna R, Morelli M and Unfer V

Delphi consensus on the diagnostic criteria of polycystic ovary syndrome

Jan 20, 2025

Authors: Fabio Facchinetti, Alessandra Gambineri, Gianluca Aimaretti, Alberto Ferlin, Antonio Simone Laganà, Paolo Moghetti, Mario Montanino Oliva, Vittorio Unfer, Annamaria Colao

Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome

Jan 20, 2025

Authors: Arturo Bevilacqua, Cristiano Giuliani, Giovanna Di Emidio, Samuel H Myers, Vittorio Unfer, and Carla Tatone

Myo-Inositol and Its Derivatives: Their Roles in the Challenges of Infertility

Nov 16, 2024

Authors: Martina Placidi, Giovanni Casoli, Carla Tatone, Giovanna Di Emidio and Arturo Bevilacqua

Disclosing α-lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome

Oct 4, 2024

Authors: Giulia Alessandri, Leonardo Mancabelli, Federico Fontana, Elisa Lepore, Gianpiero Forte, Moira Burratti, Marco Ventura, Francesca Turroni